Dubai Conducts Trial to Assess Breath Test to Detect Coronavirus


Dubai is conducting a clinical trial to assess the accuracy of a breath test to detect the coronavirus within one minute.

The rapid test, developed by the National University of Singapore’s Breathonix Pte Ltd., is being trialled on 2,500 patients, according to a statement. Breathonix is carrying out the trial with Dubai Health Authority and Mohammed Bin Rashid University of Medicine and Health Sciences.

Machine learning software will analyze a breath sample and generate the result in less than a minute, according to the statement. Breathonix had previously conducted a Singapore-based pilot study that involved 180 patients and achieved a sensitivity of 93% and specificity of 95% with the machine learning algorithm, it said.

©2021 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.